- Home
- NYMT vs AMLX Comparison
NYMT vs AMLX Comparison
Compare NYMT & AMLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NYMT
- AMLX
- Stock Information
- Founded
- NYMT 2003
- AMLX 2014
- Country
- NYMT United States
- AMLX United States
- Employees
- NYMT N/A
- AMLX N/A
- Industry
- NYMT Real Estate Investment Trusts
- AMLX Biotechnology: Pharmaceutical Preparations
- Sector
- NYMT Real Estate
- AMLX Health Care
- Exchange
- NYMT Nasdaq
- AMLX Nasdaq
- Market Cap
- NYMT 539.9M
- AMLX 481.9M
- IPO Year
- NYMT 2004
- AMLX 2022
- Fundamental
- Price
- NYMT $5.96
- AMLX $4.76
- Analyst Decision
- NYMT Buy
- AMLX Buy
- Analyst Count
- NYMT 5
- AMLX 7
- Target Price
- NYMT $7.88
- AMLX $6.00
- AVG Volume (30 Days)
- NYMT 934.7K
- AMLX 1.7M
- Earning Date
- NYMT 10-30-2024
- AMLX 11-07-2024
- Dividend Yield
- NYMT 13.42%
- AMLX N/A
- EPS Growth
- NYMT N/A
- AMLX N/A
- EPS
- NYMT N/A
- AMLX N/A
- Revenue
- NYMT $252,541,000.00
- AMLX $196,485,000.00
- Revenue This Year
- NYMT N/A
- AMLX N/A
- Revenue Next Year
- NYMT $26.56
- AMLX $149.49
- P/E Ratio
- NYMT N/A
- AMLX N/A
- Revenue Growth
- NYMT 139.48
- AMLX N/A
- 52 Week Low
- NYMT $5.14
- AMLX $1.58
- 52 Week High
- NYMT $9.67
- AMLX $19.95
- Technical
- Relative Strength Index (RSI)
- NYMT 57.22
- AMLX 45.23
- Support Level
- NYMT $5.57
- AMLX $4.88
- Resistance Level
- NYMT $6.23
- AMLX $7.27
- Average True Range (ATR)
- NYMT 0.22
- AMLX 0.59
- MACD
- NYMT 0.06
- AMLX -0.18
- Stochastic Oscillator
- NYMT 75.23
- AMLX 7.03
About NYMT New York Mortgage Trust Inc.
New York Mortgage Trust Inc is a real estate investment trust for federal income tax purposes, in the business of acquiring, investing in, financing and managing mortgage-related and residential housing-related assets. The company's investment portfolio consists of Structured multi-family property investments such as multi-family CMBS an preferred equity in, and mezzanine loans to owners of multi-family properties. Distressed residential assets such as residential mortgage loans sourced from distressed markets and non-Agency RMBS. Second mortgages, Agency RMBS, and certain other mortgage-related and residential housing-related assets.
About AMLX Amylyx Pharmaceuticals Inc.
Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder.